ABBV logo AbbVie +
AbbVie
+

AbbVie (ABBV) Business News

Track AbbVie in real time with a live news feed covering AbbVie stock news, official press releases, company announcements, and an archive of historical AbbVie news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

5 High-Yield Dividend Stocks That Could Beat a 5% Treasury Yield

247 Wallst

10:47 AM | Friday | Nov 13, 2026

news photo
Loading...

Treasuries now pay 5.1% with zero equity risk, so dividend stocks have to earn their place in an income portfolio. Five payers pass a stricter test than yield alone, and one of them yields barely half the Treasury rate.

Read full article redirect
10:47 AM | Friday | Nov 13, 2026

5 High-Yield Dividend Stocks That Could Beat a 5% Treasury Yield

247 Wallst

Treasuries now pay 5.1% with zero equity risk, so dividend stocks have to earn their place in an income portfolio. Five payers pass a stricter test than yield alone, and one of them yields barely half the Treasury rate.

Read full article arrow
News Thumbnail
4:44 AM | Friday | Nov 13, 2026

3 Dividend Stocks Built for a Market Priced Like It's 1999

Fool - Investing News

With stocks arguably priced like it's 1999, these three dividend payers could help you weather what comes next.

Read full article arrow
News Thumbnail
12:12 PM | Thursday | Nov 12, 2026

3 Pharmaceutical Stocks That Offer Safety and Growth

MarketBeat

Market volatility is unpleasant, but it's important that investors don't force themselves into a false choice between safety and growth. Over the last two years, technology stocks, particularly AI stocks, have driven strong portfolio gains for active and passive investors.

Read full article arrow
News Thumbnail
12:41 PM | Wednesday | Nov 11, 2026

ABBV Stock Rises More Than 4% in a Month: Time to Buy, Hold or Sell?

Zacks Investment Research

AbbVie's strong immunology and neuroscience growth offset Humira erosion and persistent aesthetics and oncology challenges.

Read full article arrow
News Thumbnail
3:53 AM | Tuesday | Nov 10, 2026

AbbVie Inc. $ABBV Stock Bought by AlphaCore Capital LLC

Defense World

AlphaCore Capital LLC grew its stake in AbbVie Inc. (NYSE: ABBV) by 11.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,568 shares of the company's stock after acquiring an additional 5,092 shares during the period. AlphaCore Capital LLC's

Read full article arrow
News Thumbnail
4:03 AM | Monday | Nov 9, 2026

CenterBook Partners LP Purchases New Stake in AbbVie Inc. $ABBV

Defense World

CenterBook Partners LP acquired a new stake in AbbVie Inc. (NYSE: ABBV) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 7,216 shares of the company's stock, valued at approximately $1,888,000. A number of other hedge funds have also added to

Read full article arrow
News Thumbnail
12:45 PM | Sunday | Nov 8, 2026

Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications

PRNewsWire

– HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statistically significant improvements in satisfaction with facial appearance and skin quality following a treatment regimen that also included skincare – Interim results from HALO, a Phase 4 study of hyaluronic acid (HA) injectables in adults on GLP-1 medications, showed high patient satisfaction, with 95.7% of participants satisfied or very satisfied that they still looked like themselves – The findings are part of a broad Allergan Aesthetics scientific program at ASDS 2026, advancing research across medical weight loss, multimodal treatment, neurotoxin innovation and skin quality IRVINE, Calif.

Read full article arrow
News Thumbnail
2:46 PM | Saturday | Nov 7, 2026

How Much Do You Need in a Roth IRA at 58 to Replace a $120,000 Salary Tax-Free?

247 Wallst

Quitting at 58 sounds simple when your savings sit in a Roth. But one hidden clock, and the wrong conversion pulled at the wrong time, can turn tax-free money into a penalty bill. Find out which dates to check before you walk out.

Read full article arrow
News Thumbnail
12:47 PM | Friday | Nov 6, 2026

$600,000 in Dividend Stocks: How a Roth IRA Could Save You $4,460 a Year

247 Wallst

Six household-name dividend payers hand you a steady paycheck, but one of them gets taxed far harder than the other five. Find out which holding belongs in a Roth first, and how the bill snowballs over two decades.

Read full article arrow
News Thumbnail
11:17 AM | Thursday | Nov 5, 2026

5 High-Yield Dividend Stocks Paying Up to 6% With Payouts Built to Last

24/7 Wall Street

A fat yield means nothing if the check bounces. Five payers across telecom, tobacco, pharma, real estate and pipelines show how to test coverage, and one of them carries a debt pile that could threaten its raise streak.

Read full article arrow
News Thumbnail